BioCryst Pharmaceuticals Grants Inducement Stock Options to New Hire Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Pharmaceuticals granted 18,300 restricted stock units (RSUs) to a newly-hired employee as inducement for their employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs vest in four equal annual installments, subject to the employee's continued service with the company. The grant was made under BioCryst's Inducement Equity Incentive Plan and a restricted stock unit agreement.